Stock listing

KTTA Stock Price, News, Filings & Events — Pasithea Therapeutics Corp.

Selected listing: KTTA · NASDAQ · USD · US

This page tracks Pasithea Therapeutics Corp.'s KTTA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KTTA:NASDAQ. KTTA:NASDAQ is the stock-level entry point for investors researching Pasithea Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pasithea Therapeutics Corp. is a public company traded under the ticker KTTA in the American market. The company has a market capitalization of approximately $15.2 million. Pasithea focuses on developing innovative therapies, although specific details about its products or services are not provided.

KTTA:NASDAQUSDUSUpdated September 11, 2026
Pasithea Therapeutics Corp. logo
Ticker
KTTA:NASDAQ
Asset type
Stock
Market cap
$17.7M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Pasithea Therapeutics Corp. KTTA:NASDAQ stock context

This page tracks Pasithea Therapeutics Corp.'s KTTA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KTTA:NASDAQ. KTTA:NASDAQ is the stock-level entry point for investors researching Pasithea Therapeutics Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pasithea Therapeutics Corp. is a public company traded under the ticker KTTA in the American market. The company has a market capitalization of approximately $15.2 million. Pasithea focuses on developing innovative therapies, although specific details about its products or services are not provided.

Latest news from Pasithea Therapeutics Corp.

All Pasithea Therapeutics Corp. news →

Research Pasithea Therapeutics Corp.

Alternate listings